CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.28
USD
-0.19 (-0.36%)
Streaming Delayed Price
/ Updated:
12:29 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
SEC Filings
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
656,008
Open
52.33
Bid (Size)
52.28 (400)
Ask (Size)
52.29 (1200)
Prev. Close
52.47
Today's Range
52.08 - 52.40
52wk Range
41.68 - 54.00
Shares Outstanding
2,459,950,090
Dividend Yield
3.99%
Top News
More News
No More Secrets: Medtronic Shows How Open Science Might Work In The Real World
Today 11:31 EDT
Monday night, two groups of researchers released independent reviews of a back surgery device made by Medtronic, the $16 billion (sales) medical device giant. They found the product, Infuse, was no...
Read More
category
NYSE:MRK
,
NYSE:GSK
,
NYSE:MDT
from
Forbes Real Time
3 New Fat-Busting Supplements For Speedy Weight Loss
Today 9:25 EDT
How much more news about weight loss supplements can there be to share? More every year, it turns out, as researchers synthesize new plant-derived compounds and test methods to optimize them for...
Read More
category
NYSE:GSK
from
Forbes Real Time
Amarin (AMRN) Vascepa Prescriptions Still Showing Strong Growth (GSK)
Today 7:51 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8429997 for the full story.
Read More
from
StreetInsider.com News Articles
Call for overhaul of drug industry business model
June 18, 2013
Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by...
Read More
from
FOX News
More News
Read More
RDInvesting Provides Investors with Free In-Depth Equity Reports on CSIQ, GSK, KSS and LMT
June 18, 2013
from
ACCESSWIRE
GlaxoSmithKline (GSK) Receives Bid for Thrombosis Brands, NDB Site
June 18, 2013
from
StreetInsider.com News Articles
S.Africa's Aspen offers to buy GSK thrombosis drugs
June 18, 2013
category
companyNews
from
Reuters: Company News
Royalty Pharma’s bid for Elan in jeopardy
June 17, 2013
category
Theravance Inc/
,
Rory Riggs
,
Health Care
, and 4 more.
from
Business Journals
UPDATE 1-Royalty hostile bid for Elan in doubt after vote
June 17, 2013
category
companyNews
from
Reuters: Company News
Elan shareholders approve buyback in blow to Royalty bid
June 17, 2013
from
FOX News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here